These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 24913302

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Anterior Segment Seeding in Eyes With Retinoblastoma Failing to Respond to Intraophthalmic Artery Chemotherapy.
    Pavlidou E, Burris C, Thaung C, Scheimberg I, Kingston J, Hungerford JL, Reddy MA, Sagoo MS.
    JAMA Ophthalmol; 2015 Dec; 133(12):1455-8. PubMed ID: 26334520
    [Abstract] [Full Text] [Related]

  • 24. Oxidative stress in retinoblastoma: correlations with clinicopathologic features and tumor invasiveness.
    Deepa PR, Nalini V, Mallikarjuna K, Vandhana S, Krishnakumar S.
    Curr Eye Res; 2009 Dec; 34(12):1011-8. PubMed ID: 19958119
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
    Shields CL, Manjandavida FP, Lally SE, Pieretti G, Arepalli SA, Caywood EH, Jabbour P, Shields JA.
    Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
    Uusitalo MS, Van Quill KR, Scott IU, Matthay KK, Murray TG, O'Brien JM.
    Arch Ophthalmol; 2001 Jan; 119(1):41-8. PubMed ID: 11146725
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
    Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA.
    J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
    [Abstract] [Full Text] [Related]

  • 36. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
    Yannuzzi NA, Francis JH, Marr BP, Belinsky I, Dunkel IJ, Gobin YP, Abramson DH.
    JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors.
    Chong EM, Coffee RE, Chintagumpala M, Hurwitz RL, Hurwitz MY, Chévez-Barrios P.
    Arch Pathol Lab Med; 2006 Nov; 130(11):1669-72. PubMed ID: 17076529
    [Abstract] [Full Text] [Related]

  • 40. The International Classification of Retinoblastoma predicts chemoreduction success.
    Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2006 Dec; 113(12):2276-80. PubMed ID: 16996605
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.